National and Kapodistrian University of Athens
Μελέτη συμπλόκων ρηνίου ως νέων αντικαρκινικών παραγόντων
Abstract
dc:descriptionIn this PhD thesis, novel rhenium complexes were designed, synthesized and characterized in oxidation states (V) and (I) and were studied for their antitumor activity.In the first category, the rhenium complexes belong to the oxidation state (V) and their general formula is ReO(SNO)(NN) (category 1), where SNO is the tridentate ligand N-(2-mercaptopropionyl)glycine (CH3-SNO) or N-(2-mercaptoacetyl)glycine (SNO) and the NN bidentate ligand is the 2,2'-bipyridine (bpy) or 7-fluorodipyrido[3,2-a:2΄,3΄-c]-phenazine (F-dppz), or benzo[i]bipyrido[3,2-a:2',3'-c]phenazine (dppn), where F-dppz and dppn are intercalators. The complexes with bpy, ReO(CH3-SNO)(bpy) and ReO (SNO) (bpy) were used as reference compounds.All of the oxorhenium complexes (ReO(CH3-SNO) (bpy), ReO(SNO)(bpy), ReO(CH3-SNO)(F-dppz), ReO(SNO)(F-dppz) and ReO(CH3-SNO)(dppn)) were synthesized by reacting the ReOCl3(PPh3)2 precursor with the tridentate and the bidentate ligand in methanol in good yields (70 – 80%). The complexes were characterized by elemental analysis, IR and NMR spectroscopy. The IR and NMR spectroscopies and X-Ray crystallography revealed the existence of two diastereomers syn and anti for the complex with the CH3-SNO tridentate ligand. The structure of the complexes syn-ReO(CH3-SNO)(bpy), anti-ReO(CH3-SNO)(bpy), ReO(SNO)(bpy) and ReO(SNO)(F-dppz) was confirmed by X-Ray crystallography.The oxorhneium complexes were studied for their cytotoxicity against the human cancer cell line, HeLa (cervical) by the MTT method. The ReO(CH3-SNO)(F-dppz) complex exhibited the greatest cytotoxic activity with IC50 ~ 10 μM. The rest of the complexes in this series displayed IC50 values in the same order of magnitude (IC50 = 10.71 ‒ 16.77 μM).Thereafter, rhenium complexes were synthesized in the oxidation state (I) with the general formula [Re(CO)3(NN)L]0/+ (category 2) where the bidentate ligands are the same with the category 1 (F-dppz, dppn) and bromine (Br), acetonitrile (MeCN), cyclohexylisocyanide (cisc) and 1,3,5-triaza-7-phosphadamantane (PTA) were used as monodentate ligands completing the coordination sphere of the metal. The resulting complexes were Re(CO)3(F-dppz)Br, [Re(CO)3(F-dppz)(MeCN)]PF6, [Re(CO)3(F-dppz)(cisc)]PF6, [Re(CO)3(F-dppz)(PTA)]PF6, Re(CO)3(dppn)Br, [Re(CO)3(dppn)(cisc)]PF6 and [Re(CO)3(dppn)(PTA)]PF6.[108]The cationic complexes [Re(CO)3(F-dppz)(MeCN)]PF6 and [Re(CO)3(dppn)(MeCN)]PF6 were obtained by reacting the corresponding neutral complexes Re(CO)3(F-dppz)Br and Re(CO)3(dppn)Br with AgPF6 in acetonitrile. The [Re(CO)3(F-dppz)(MeCN)]PF6 and [Re(CO)3(dppn)(MeCN)]PF6 were used as intermediate complexes by reacting them with the monodentate ligands cisc or PTA in chloroform or methanol. The cationic complexes [Re(CO)3(F-dppz)(cisc)]PF6, [Re(CO)3(F-dppz)(PTA)]PF6, [Re(CO)3(dppn)(cisc)]PF6 and [Re(CO)3(dppn)(PTA)]PF6 were synthesized in high yields (77 – 91%). The complexes were characterized by elemental analysis, IR and NMR spectroscopy. The structure of [Re(CO)3(F-dppz)(MeCN)]PF6 was confirmed by X-ray crystallography.The cytotoxicity of the complexes of category 2 was studied against human cancer cell lines HeLa (cervical) and MCF-7 (breast). The complexes Re(CO)3(F-dppz)(cisc) and Re(CO)3(dppn)(cisc) showed the highest toxicity (IC50 = 0.13 - 6.14 μM) against both cancer cell lines.In the third and last category, the general formula of the complexes is fac-[Re(CO)3(NNbz)L]0/+ (category 3) where the bidentate ligand is the 4-(benzo[d]thiazol-2-yl)-N-(pyridin-2-ylmethyl)aniline) (NNbz) and as monodenate ligands were used bromine (Br), acetonitrile (MeCN), cyclohexylisocyanide (cisc), triphenylphosphine (PPh3), 1,3,5-triaza-7-phosphadamantane (PTA) and pyridine (py). The resulting complexes were Re(CO)3(NNbz)Br, [Re(CO)3(NNbz)(MeCN)]PF6, [Re(CO)3(NNbz)(cisc)]PF6, [Re(CO)3(NNbz)(PPh3)]PF6, [Re(CO)3(NNbz)(PTA)]PF6 and [Re(CO)3(NNbz)(py)]PF6.The cationic complex [Re(CO)3(NNbz)(MeCN)]PF6 was used as the intermediate complex and resulted from the reaction of the neutral complex Re(CO)3(NNbz)Br with AgPF6 in acetonitrile. The intermediate complex [Re(CO)3(NNbz)(MeCN)]PF6 reacts with the monodentate ligands cisc or PPh3 or PTA or py in chloroform or methanol to give the cationic complexes [Re(CO)3(NNbz)(cisc)]PF6, [Re(CO)3(NNbz)(PPh3)]PF6, [Re(CO)3(NNbz)(PTA)]PF6 and [Re(CO)3(NNbz)(py)]PF6. The complexes were synthesized in high yields (81‒94%) and characterized by IR, NMR and elemental analysis. The structure of the Re(CO)3(NNbz)Br, [Re(CO)3(NNbz)(OH2)]PF6, [Re(CO)3(NNbz)(PPh3)]PF6 and [Re(CO)3(NNbz)(PTA)]PF6 was confirmed by X-ray crystallography.The cellular uptake studies using fluorescence microscopy revealed that the complexes penetrate the cell membrane and diffuse into the cytoplasm.[109]Moreover, the cytotoxicity of the complexes of the category 3 were tested in human cancer cell lines, HeLa (cervical), MCF-7 (breast) and A431 (epidermoid) by the MTT method. The results were very encouraging. The complexes with the highest cytotoxicity against the cancer cell lines were Re(CO)3(NNbz)(cisc) and Re(CO)3(NNbz)(PPh3) (IC50 = 0.19 ‒ 0.61 μM).In addition, the interaction of all the complexes with CT-DNA was achieved by circular dichroism, competitive fluorescence studies and viscometry. The results suggest the strong interaction between the complexes and DNA via intercalation.Morover, cell cycle studies were performed for the complexes of category 3. The complex Re(CO)3(NNbz)(cisc) was found to increase the cell population in both the G1 and G2 phase by completely disruption of the cell cycle in the HeLa and MCF-7 cancer cell lines. The rest of the complexes increase the cell population in the G2/M phase.Furthermore, 99mTc(CO)3(NNbz)(cisc) was successfully synthesized in high yield (> 95%) using the precursor [99mTc(CO)3(OH2)]+. The in vivo biodistribution studies of 99mTc(CO)3(NNbz)(cisc) in healthy and SCID mice bearing tumor showed satisfactory uptake of the complex in tumor.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Roupa, Ioanna
- Ρούπα, Ιωάννα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46150